Jupiter Topco LLC Makes New Investment in Danaher Corporation $DHR

Jupiter Topco LLC bought a new position in shares of Danaher Corporation (NYSE:DHRFree Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 7,645,709 shares of the conglomerate’s stock, valued at approximately $1,456,317,000. Jupiter Topco LLC owned approximately 1.09% of Danaher at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Sivia Capital Partners LLC grew its holdings in Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after acquiring an additional 119 shares during the period. First Trust Advisors LP lifted its holdings in Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after acquiring an additional 14,217 shares during the period. Main Street Financial Solutions LLC boosted its position in shares of Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC boosted its position in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after purchasing an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC grew its stake in shares of Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after purchasing an additional 325 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.3%

DHR opened at $215.78 on Wednesday. The firm has a market cap of $151.69 billion, a P/E ratio of 38.33, a PEG ratio of 2.68 and a beta of 0.78. The business’s fifty day simple moving average is $197.17 and its 200 day simple moving average is $192.36. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.77 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on DHR. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. TD Cowen lowered their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. DZ Bank began coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Guggenheim decreased their price target on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $228.91.

Read Our Latest Analysis on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.